Max Healthcare Institute Limited has received significant relief in its GST appeal case, with the tax demand being substantially reduced following a partially favorable order from the Commissioner of Central Tax Appeal-II, Delhi.

Appeal Order Details

The company disclosed receiving the appeal order on February 20, 2026, which provided partial relief from the earlier GST demand. The order relates to alleged discrepancies in Goods and Services Tax provisions involving Input Tax Credit and tax recovery for the period from FY 2017-18 to FY 2020-21.

Significant Reduction in Demand

The appeal has been partly allowed, resulting in a substantial deletion of the original demand. The tax authority deleted GST demand of ₹1,67,32,520, penalty demand of ₹1,68,32,520, and interest demand of ₹27,217 from the original assessment.

Original vs Revised Demand Comparison

Company's Response and Next Steps

Max Healthcare Institute has indicated that the management is in the process of filing a further appeal against the order for the balance GST demand. The company stated that other than the amount to be paid, there is no other impact on the financial, operational, or other activities of the company.

Regulatory Compliance

This disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also hosted this information on its website at www.maxhealthcare.in as part of its transparency and compliance obligations.

The development represents a continuation of the company's earlier intimation dated January 23, 2025, regarding the original GST demand order received on January 22, 2025.

Max Healthcare Institute Limited has announced its participation in two significant investor conferences scheduled for February 2026. The company will engage with investors and analysts through presentations at these key industry events.

Conference Schedule

The healthcare provider has outlined its participation in the following conferences:

Regulatory Compliance

This announcement has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was communicated to both the National Stock Exchange of India Limited and BSE Limited on February 7, 2026.

Company Profile Overview

Max Healthcare Institute Limited operates as India's largest hospital chain in terms of market capitalization and second largest in terms of revenue and EBITDA. The company maintains a comprehensive network of healthcare facilities with over 5,200 beds across multiple locations.

Key Operational Highlights

The company's network includes:

• 20 healthcare facilities across North India and Mumbai
• State-of-the-art tertiary and quaternary care hospitals in key metropolitan areas
• Multiple medical centres providing specialized healthcare services
• Homecare and pathology businesses under Max@Home and Max Labs brands

Strategic Focus Areas

Max Healthcare Institute Limited continues to focus on clinical excellence, patient care, and technological advancement. The company's participation in these investor conferences demonstrates its commitment to maintaining transparent communication with stakeholders and the investment community.

The presentations will provide investors with insights into the company's operational performance, strategic initiatives, and future growth plans. These engagements are part of the company's regular investor relations activities aimed at keeping stakeholders informed about business developments and market positioning.